Stroke Management Market Size, Trends, Share Analysis, Size And Forecast To 2033

The new report published by The Business Research Company, titled Stroke Management Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the stroke management market size has grown strongly in recent years. It will grow from $36.94 billion in 2023 to $39.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The stroke management market size is expected to see strong growth in the next few years. It will grow to $52.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9988&type=smp

Rising Incidence Of Chronic Diseases Fuels Growth In The Stroke Management Market
The increasing incidence of chronic diseases is expected to propel the growth of the stroke management market going forward. Chronic diseases refer to a problem that persists for a year or longer and impedes everyday activities, necessitates continuing medical care, or both. Stroke management assists patients suffering from various chronic diseases, such as cancer and cardiovascular diseases, by providing a timely focus on preventive, care, and support requirements through patient education and empowerment as well as the creation of care delivery models that integrate primary and secondary care. For instance, in January 2023, according to the National Library of Medicine a US-based biomedical library highlights, there will be 142.66 million people aged 50 and older in 2050 who have at least one chronic disease, up from 71.522 million in 2020, a 99.5% rise. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market going forward.

Technological Innovations Drive Advancements In The Stroke Management Market
Technological advancements are a key trend gaining popularity in the stroke management market. Companies operating in the stroke management market are adopting new technologies to sustain their position in the market. For instance, in November 2021, Qure.ai, an India-based artificial intelligence solution company, launched an AI stroke management platform to enable the remote diagnosis of emergency stroke cases. The AI imaging solution developed by the startup, called qER, powers the Qure.ai Stroke Management Platform. It is a triage and notification tool approved by the US FDA under 510(k) that can identify and quantify up to 12 abnormalities on head CT scans, including bleed, fracture, mass effect, and midline displacement. It aids in the early detection of stroke. Neurologists, radiologists, and neurosurgeons are among the stroke stakeholders who can examine clinical and imaging data using a companion mobile app for the stroke management system. It creates PDF reports and allows the viewing of DICOM files. Clinicians may share photos and reports, alter AI results, and more using the app.

The stroke management market covered in this report is segmented -

1) By Product Type: Diagnostics, Drug Therapy Products, Interventional Stroke Management Systems
2) By Application: Ischemic Stroke, Hemorrhagic Stroke
3) By End-User: Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Retail Pharmacies, Online Pharmacies, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9988&type=discount

Major companies operating in the stroke management market report are GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Glaxosmithkline Plc, Siemens AG, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc., Integer Holdings Corporation

Contents of the report:
1. Executive Summary
2. Stroke Management Market Report Structure
3. Stroke Management Market Trends And Strategies
4. Stroke Management Market - Macro Economic Scenario
5. Stroke Management Market Size And Growth
…..
27. Stroke Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/stroke-management-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.